Jeffrey Stavenhagen
Directeur Technique/Scientifique/R&D chez DIANTHUS THERAPEUTICS, INC.
Profil
Jeffrey Stavenhagen is currently the Chief Scientific Officer at Dianthus Therapeutics, Inc. He previously held the same position at Therini Bio, Inc. from 2019 to 2023.
He obtained a doctorate degree from The Trustees of Columbia University in The City of New York.
Postes actifs de Jeffrey Stavenhagen
| Sociétés | Poste | Début |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 29/11/2023 |
Anciens postes connus de Jeffrey Stavenhagen
| Sociétés | Poste | Fin |
|---|---|---|
Therini Bio, Inc.
 Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Directeur Technique/Scientifique/R&D | 01/12/2023 |
Formation de Jeffrey Stavenhagen
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Therini Bio, Inc.
Therini Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Therini Bio, Inc. engages in research and development in the field of biotechnology. The company was founded by Katerina Akassoglou in 2016 and is headquartered in San Francisco, CA. | Commercial Services |